STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #432 by analyst upside · 2026-08-14
OPK
OPKO Health, Inc.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
+212.5%
implied upside to consensus target
Current Price $1.4
Consensus Target $4.38
Bull Target $8.5
Bear Target $3.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
1
Hold
1
Sell
1
52-Week Low $0.98
52-Week High $1.73
YTD Return +10.2%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.07
PEG Ratio 93.65
Dividend Yield N/A
Revenue (TTM) $588M
Profit Margin -12.4%
52-WEEK RANGE
52-Week Low $0.98
52-Week High $1.73
Current Price $1.4
Bear Target $3.0
Bull Target $8.5
● Now $1.4 ● Target $4.38
TRADING DATA
Avg Volume 3.6M
YTD Return +10.2%
Analyst Count 4
Consensus Buy
Upside to Target +212.5%
Last Updated 2026-08-14

ANALYST SUMMARY

OPKO Health, Inc. (OPK) is currently trading at $1.4 with a Wall Street consensus price target of $4.38, implying potential upside of 212.5% over the next 12 months. 4 analysts currently cover OPK, with a consensus rating of Buy - 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $8.5, while the most cautious has a target of $3.0.

OPK operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 10.2% year-to-date and is currently trading near the upper end of its 52-week range of $0.98 – $1.73.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for OPK, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barrington Research ↓ Downgrade
Outperform → Market Perform 2026-04-29 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-03-02 Building track record
JP Morgan ● Initiated
Neutral 2025-11-20 43% win rate (7 calls)
Jefferies ↓ Downgrade
Buy → Hold 2025-10-31 50% win rate (6 calls)
Barrington Research - Reiterated
Outperform → Outperform 2025-10-30 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2025-05-01 Building track record
JP Morgan ● Initiated
Neutral 2025-04-25 43% win rate (7 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-04-07 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
19
out of 100
Coverage depth
12/30
Consensus clarity
0/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →